Literature DB >> 26850322

Components of the lectin pathway of complement activation in paediatric patients of intensive care units.

Anna S Świerzko1, Agnieszka Szala-Poździej1, David C Kilpatrick2, Michał Sobociński3, Karolina Chojnacka4, Anna Sokołowska1, Mateusz Michalski5, Karolina Mazerant1, Jens C Jensenius6, Misao Matsushita7, Wojciech R Krajewski3, Jerzy Szczapa4, Leokadia Bąk-Romaniszyn8, Krzysztof Zeman9, Maciej Cedzyński10.   

Abstract

Infections are a major cause of childhood mortality. We investigated components of the lectin pathway of complement activation in the context of sepsis at both genetic and protein levels in neonates, infants and older children. Major components of the lectin pathway and two genes for Toll-like receptors were studied in 87 neonates with confirmed sepsis and compared with 40 babies with infections who did not develop sepsis (disease controls) and 273 infection-free neonatal controls. A second cohort comprised 47 older children with sepsis and 87 controls. Low MBL-conferring genotypes (LXA/O+O/O) were more frequent in sepsis patients than in healthy controls but no significant differences in the frequency of SNPs of other lectin pathway genes (FCN1, FCN2, FCN3, MASP1/3, MASP2) or TLR receptor genes (TLR2, TLR4) were found. One case of primary MASP-2 deficiency was found among healthy pre-terms and one neonate suffering from SIRS was heterozygous for the rare FCN1 gene mutation, +6658 G>A. Generally, sepsis was associated with low serum MBL and low ficolin-2 concentrations on admission. Among neonates, ficolin-1 and MASP-2 levels were elevated in sepsis relative to healthy, but not disease, controls. Unlike neonates, ficolin-3 and MASP-2 levels were lower in older patients than in healthy controls while no difference was found for ficolin-1. With the possible exception of MBL, inherited lectin pathway insufficiencies do not seem to predispose to sepsis, rather changes in protein concentrations reflect alterations in disease course.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  ); Complement; Ficolin; Innate immunity; MASP; Mannose-binding lectin (mannan-binding lectin, MBL; Sepsis

Mesh:

Substances:

Year:  2016        PMID: 26850322     DOI: 10.1016/j.imbio.2016.01.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  Lectin pathway factors in patients suffering from juvenile idiopathic arthritis.

Authors:  Katarzyna Kasperkiewicz; Łukasz Eppa; Anna S Świerzko; Marcin A Bartłomiejczyk; Zbigniew M Żuber; Katarzyna Siniewicz-Luzeńczyk; Elżbieta Mężyk; Misao Matsushita; Leokadia Bąk-Romaniszyn; Krzysztof Zeman; Mikael Skurnik; Maciej Cedzyński
Journal:  Immunol Cell Biol       Date:  2017-04-13       Impact factor: 5.126

2.  Lectin complement pathway proteins in healthy individuals.

Authors:  A Troldborg; A Hansen; S W K Hansen; J C Jensenius; K Stengaard-Pedersen; S Thiel
Journal:  Clin Exp Immunol       Date:  2017-01-18       Impact factor: 4.330

Review 3.  Association between innate immunity gene polymorphisms and neonatal sepsis development: a systematic review and meta-analysis.

Authors:  Tamara Sljivancanin Jakovljevic; Jelena Martic; Jelena Jacimovic; Nadja Nikolic; Jelena Milasin; Tanja Lazić Mitrović
Journal:  World J Pediatr       Date:  2022-06-06       Impact factor: 9.186

4.  Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults.

Authors:  Anna Sokołowska; Anna S Świerzko; Gabriela Gajek; Aleksandra Gołos; Mateusz Michalski; Mateusz Nowicki; Agnieszka Szala-Poździej; Anna Wolska-Washer; Olga Brzezińska; Agnieszka Wierzbowska; Krzysztof Jamroziak; Marek L Kowalski; Steffen Thiel; Misao Matsushita; Jens C Jensenius; Maciej Cedzyński
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

5.  Factors involved in initiation and regulation of complement lectin pathway influence postoperative outcome after pediatric cardiac surgery involving cardiopulmonary bypass.

Authors:  Mateusz Michalski; Izabela Pągowska-Klimek; Steffen Thiel; Anna S Świerzko; Annette G Hansen; Jens C Jensenius; Maciej Cedzyński
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

6.  European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management.

Authors:  Nicholas Brodszki; Ashley Frazer-Abel; Anete S Grumach; Michael Kirschfink; Jiri Litzman; Elena Perez; Mikko R J Seppänen; Kathleen E Sullivan; Stephen Jolles
Journal:  J Clin Immunol       Date:  2020-02-17       Impact factor: 8.317

Review 7.  The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System.

Authors:  Anna S Świerzko; Maciej Cedzyński
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.